“Cell culture and animal studies show that the new TriSb92 molecule developed by researchers protects against coronavirus infection for at least eight hours, even in cases of high risk of infection. Unlike the protection provided by the vaccine, the effect of TriSb92 begins immediately after its introduction,” the university’s website notes.
One of the authors of the study, Anna Myakelya, explained that this molecule protected mice that received it through the nose from coronavirus, while other mice were infected.
Myakelya stated that TriSb92 can suppress the ability to infect all known strains of coronavirus, including omicron. It is noted that the molecule does not compete with the vaccine, but is an addition to it.
According to the National Institute of Health and Welfare of Finland, since the beginning of the epidemic in Finland, more than 328 thousand cases of coronavirus infection and 1,656 deaths have been detected.